Varenicline tartrate API powder

Product Name: Varenicline tartrate API powder
CAS NO.:375815-87-5
Molecular formula:C17H19N3O6
EINECS:638-780-5
Synonyms:Champix;CP 526555-18;
Shelf life: 24 months
Purity : 98% HPLC
Certificate:COA; HPLC; MSDS; TDS,etc.
MOQ : 1g;10g;100g
Shipping: DHL/FedEx/UPS/USPS Safe and fast delivery
Lead Time: 1-3 days
Warehouse: USA and Germany warehouse

Product Description

Xi'an Faithful BioTech Co., Ltd: Your Trusted Varenicline tartrate API powder Manufacturer & Supplier

Xi'an Faithful BioTech Co., Ltd was founded in 2018. Headquartered in the ancient capital of Xi'an, we are a high-quality supplier of Varenicline tartrate API powder in the northwest region. We focus on the production and sales of pharmaceutical intermediates, with products covering multiple key chemical structural units. We are committed to providing high-purity and cost-effective raw material support for global pharmaceutical companies. We have won the recognition of our customers with our excellent product quality and honest management philosophy.

Varenicline tartrate API powder Introduction

The Varenicline tartrate API powder is a partial alpha 4 β 2 nicotinic acetylcholinesterase agonist with an EC50 of 2.3 mM and an efficacy of 13.4% (relative to acetylcholinesterase), approved by the US Food and Drug Administration (FDA) for smoking cessation. It can effectively alleviate the craving and withdrawal symptoms of smoking, and can help reduce the pleasure of smoking during the 12 week treatment. The appearance is white powder. Our Varenicline tartrate API has undergone improved production processes to ultimately produce stable crystalline powders, making it the top choice for both research and production.

Specifications

Item	Specification		Result
Appearance	Off-white to light fawn powder		Light fawn powder
Identification	IR, HPLC		Confirm
Solubility	Freely soluble in water, slightly soluble in N, N - dimethyl formamide		Confirm
Loss on Drying	≤0.5%		0.1%
Residue on Ignition	≤0.2%		0.04%
Substances	2,2,2-trifluoro-1-(6,7,9,10-t etrahydro-8H-6,10-methan oazepino[4,5-g]quinoxalin- 8-yl)e than-1-one (Code:333110)	≤0.10%	≤0.02%
	Any other individual impurity	≤0.10%	≤0.05%
	Total impurities	≤0.5%	≤0.1%
Assay(By HPLC)(on the dried basis)	98.0~102.0%		99.9%
Residual solvents	Ethanol	≤5000ppm	3505ppm
	Isopropanol	≤5000ppm	18ppm
	Dichloromethane	≤600ppm	8ppm
Content of Tartaric Acid (on the dried basis)	40.7%~42.3%		41.6%
Content of Palladium	≤10ppm		N/A
Conclusion：	Conform with enterprise specification

Why Choose Us?

Rich product matrix

Covering the entire category of active pharmaceutical ingredients, intermediates, excipients, etc., meeting the needs of multiple fields such as pharmaceuticals, health products, biotechnology, etc.
Adequate inventory, popular products such as vitamins and antibiotic raw materials can quickly respond to orders.

A stable supply chain system

Deeply cooperate with global leading pharmaceutical companies and compliant suppliers to ensure reliable sources of raw materials.
Flexible logistics solutions (such as combining air and sea freight), supporting urgent order processing.

Main applications

Varenicline tartrate API powder related preparations are suitable as drugs for adult smoking cessation and are one of the highly effective smoking cessation drugs both domestically and internationally.
It can also be used to prevent or treat the following diseases: inflammatory bowel disease (including but not limited to ulcerative colitis, pyoderma gangrene, and Crohn's disease), irritable bowel syndrome, spastic muscle tone disorder, chronic pain, acute pain, abdominal irrigation, vasoconstriction, anxiety, panic disorder, depression, bipolar disorder, autism, sleep disorders, jet lag, amyotrophic lateral sclerosis (ALS), cognitive dysfunction, etc.

if you need it , you can click here